04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Welcome to your weekly update from the Allen & Overy Pensions team, bringing you up to speed on the ...
Read More >
On January 31, 2020, United States Citizenship & Immigration Services ("USCIS") introduced a new ver...
Read More >
On January 14, 2020, the Brazilian Ministry of Economy issued an ordinance fixing the 2020 maximum p...
Read More >
On September 18, Governor Gavin Newsom signed AB 5, a bill dealing with the classification of worker...
Read More >
For plan sponsors continuing to maintain individually designed plan documents, the IRS provides an a...
Read More >
On October 7, 2020, the US Securities and Exchange Commission (“SEC”) adopted a new rule under the...
Read More >